Nocturnal Scratch as a Digital Biomarker

Itch is the symptom that matters most in inflammatory skin disease, it is worst at night, and nobody can accurately report how much they scratched while asleep.

Status
Validated
Unit
minutes/night
Data type
Duration
Sensor
Accelerometer
Worn
Wrist

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Established
Analytical validation
Established
Clinical validation
Emerging

Validated against video annotation and used as an objective endpoint in dermatology trials, with digital measures now developed jointly for scratch and sleep from one device. Algorithms are not standardised between groups, so counts are not comparable across studies.

What is Nocturnal Scratch

Nocturnal scratch is the amount of scratching a person does while asleep, reported as duration, number of events, or proportion of the night. It exists as a digital measure because of a clean mismatch between what matters clinically and what can be reported.

Itch is consistently the symptom people with atopic dermatitis rank as most burdensome, and it is worst at night. But scratching during sleep is by definition not observed by the person doing it, so morning recall is an estimate of something they were unconscious for. Bed partner reports and video are impractical at scale.

Wrist accelerometry solves that directly, and it is one of the clearest cases in this library where a digital measure captures something no questionnaire realistically can, rather than merely capturing it more often.

How it is measured

Accelerometers on one or both wrists record movement through the night, and an algorithm identifies the characteristic rhythmic pattern of scratching and separates it from other sleep movement. Early work established that wrist activity monitors could quantify nocturnal scratching in atopic dermatitis, and later approaches applied machine learning to improve discrimination.

Validation uses infrared video annotated by trained observers as the reference standard, which is why studies are typically small and conducted in controlled overnight settings.

Because the same recording contains sleep information, contemporary work has developed nighttime scratch and sleep measures together from a single wrist device, which is efficient: the disease disrupts sleep through itch, so measuring both from one sensor describes the mechanism and the consequence at once.

Clinical use

The main use is as an objective endpoint in atopic dermatitis and chronic pruritus trials, where it complements clinician assessed severity and patient reported itch. Because it is objective and continuous, it can detect change earlier and with less noise than a weekly recalled itch score.

The second use is mechanistic: pairing scratch with sleep measures from the same night shows whether reduced itch actually translated into better sleep, which is one of the outcomes patients most want and which severity scores do not capture.

Measures are reported alongside the Eczema Area and Severity Index, which is the clinician assessed counterpart, and alongside the Dermatology Life Quality Index, which captures the wider impact on daily life.

Regulatory status

No regulatory qualification as an endpoint. Objective nocturnal scratch measures appear in registered dermatology trials as supporting outcomes alongside clinician assessed severity.

Limitations

Algorithms differ between research groups and are not standardised, so scratch counts from different studies are not directly comparable. Detection has to distinguish scratching from other rhythmic sleep movement, and performance in unrestricted home settings is less well characterised than the controlled validation studies suggest.

Wrist placement misses scratching done with other body parts, and bilateral recording is more accurate but doubles the wear burden.

Reference standards are also limited: video annotation is labour intensive and involves observer judgement about when scratching starts and stops. And while the measure is objective, the amount of change that matters to a person has not been firmly established, so a reduction in scratch minutes still needs a patient reported anchor to interpret.

References

  • Mahadevan N, et al. Development of digital measures for nighttime scratch and sleep using wrist-worn wearable devices. NPJ Digit Med. 2021. pubmed.ncbi.nlm.nih.gov
  • Moreau A, et al. Detection of nocturnal scratching movements in patients with atopic dermatitis using accelerometers and recurrent neural networks. IEEE J Biomed Health Inform. 2018. pubmed.ncbi.nlm.nih.gov
  • Ebata T, et al. Use of a wrist activity monitor for the measurement of nocturnal scratching in patients with atopic dermatitis. Br J Dermatol. 2001. pubmed.ncbi.nlm.nih.gov
  • Ikoma A, et al. Measurement of nocturnal scratching in patients with pruritus using a smartwatch: initial clinical studies. Acta Derm Venereol. 2019. pubmed.ncbi.nlm.nih.gov
Devices that capture it
Related instruments

Complements the Eczema Area and Severity Index, which a clinician scores by examining the skin, and the Dermatology Life Quality Index, which captures daily impact. Neither can measure what happens during sleep, which is exactly the gap this measure fills.

Use case
Monitoring · Response
Collect Nocturnal Scratch and other digital biomarkers in one workflow. Or turn your research into a new digital biomarker?
Capture overnight wearable data alongside severity and quality of life instruments in one study workflow.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.